BlackBarn Capital Partners LP — 13F Holdings & Portfolio
CIK 2010204 · latest 13F-HR filed 2026-08-14
BlackBarn Capital Partners LP manages $1.19B in 13F-reported U.S. long-equity assets across 24 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPY (50.40%), ROIV (5.97%), OSCR (4.21%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 5 new positions, exited 2, added to 9, and trimmed 3.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
25TH FLOOR
NEW YORK, NY 10019
$1.19B
Long-equity book
24
Distinct positions
2026-06-30
Filed 2026-08-14
+5 / −2 / ↑9 / ↓3
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- NXP SEMICONDUCTORS N V$13.5M +114.1%
- PRIVIA HEALTH GROUP INC$8.2M +25.1%
- ROIVANT SCIENCES LTD$7.5M +11.8%
- DIVERSIFIED HEALTHCARE TR$5.9M +18.6%
- NIQ GLOBAL INTELLIGENCE PLC$3.6M +15.1%
Top Trims
- COGENT COMMUNICATIONS HLDGS-$6.0M -63.2%
- MCGRAW HILL INC-$5.4M -18.9%
- NEXTERA ENERGY INC-$1.7M -5.5%
New Positions
- UNITEDHEALTH GROUP INC$27.0M
- VENTURE GLOBAL INC$19.5M
- AZUL S A$15.1M
- OCCIDENTAL PETE CORP$12.1M
- CALIFORNIA RES CORP$9.3M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR Put | SPY | 78462F103 | $597.4M | 50.40% | 800,000 | SH |
| 2 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $70.8M | 5.97% | 2,000,000 | SH |
| 3 | OSCAR HEALTH INC Put | OSCR | 687793109 | $49.9M | 4.21% | 1,750,000 | SH |
| 4 | UNITEDHEALTH GROUP INC Call | UNH | 91324P102 | $41.6M | 3.51% | 100,000 | SH |
| 5 | PRIVIA HEALTH GROUP INC | PRVA | 74276R102 | $40.8M | 3.44% | 1,585,000 | SH |
| 6 | RESMED INC Put | RMD | 761152107 | $39.0M | 3.29% | 200,000 | SH |
| 7 | DIVERSIFIED HEALTHCARE TR | DHC | 25525P107 | $37.9M | 3.20% | 4,075,000 | SH |
| 8 | VENTURE GLOBAL INC Call | VG | 92333F101 | $33.4M | 2.82% | 3,000,000 | SH |
| 9 | NEXTERA ENERGY INC | NEE | 65339F101 | $29.4M | 2.48% | 335,000 | SH |
| 10 | NIQ GLOBAL INTELLIGENCE PLC | NIQ | G63755105 | $27.2M | 2.29% | 2,903,862 | SH |
| 11 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $27.0M | 2.28% | 65,000 | SH |
| 12 | NXP SEMICONDUCTORS N V | NXPI | N6596X109 | $25.3M | 2.13% | 90,000 | SH |
| 13 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $23.4M | 1.97% | 600,000 | SH |
| 14 | MCGRAW HILL INC | MH | 580907103 | $23.2M | 1.96% | 2,450,000 | SH |
| 15 | AMNEAL PHARMACEUTICALS INC | AMRX | 03168L105 | $22.5M | 1.90% | 1,300,000 | SH |
| 16 | VENTURE GLOBAL INC | VG | 92333F101 | $19.5M | 1.64% | 1,750,000 | SH |
| 17 | AZUL S A | AZUL | 05501U601 | $15.1M | 1.28% | 1,684,188 | SH |
| 18 | OCCIDENTAL PETE CORP | OXY | 674599105 | $12.1M | 1.02% | 250,000 | SH |
| 19 | WARBY PARKER INC Put | WRBY | 93403J106 | $12.1M | 1.02% | 400,000 | SH |
| 20 | ARBUTUS BIOPHARMA CORP | ABUS | 03879J100 | $12.0M | 1.01% | 2,500,000 | SH |
| 21 | VIKING THERAPEUTICS INC Call | VKTX | 92686J106 | $9.8M | 0.82% | 250,000 | SH |
| 22 | CALIFORNIA RES CORP | CRC | 13057Q305 | $9.3M | 0.78% | 175,000 | SH |
| 23 | COGENT COMMUNICATIONS HLDGS | CCOI | 19239V302 | $3.5M | 0.29% | 250,000 | SH |
| 24 | VIVID SEATS INC | SEAT | 92854T209 | $3.3M | 0.28% | 500,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $1.19B | 24 | 0002010204-26-000006 |
| 2026-03-31 | 2026-05-15 | $1.24B | 21 | 0002010204-26-000004 |
| 2025-12-31 | 2026-02-17 | $1.52B | 16 | 0002010204-26-000001 |
| 2025-09-30 | 2025-11-14 | $1.40B | 20 | 0002010204-25-000006 |